Search Existing Data Requests

The Knight ADRC has supported many investigators at Washington University and at other institutions over the years. We wish to avoid the situation where two investigators study the same research question to avoid duplication of effort and potential conflict. To determine if your topic has already been studied with our resources, please search our database. If you find that your topic or a related topic has been submitted, you may wish to contact the investigator to inquire about their findings to determine how you might proceed. You may wish to collaborate or modify your request to avoid overlap. The results below reflect requests made since online requests have been accepted. As such, not all fields will have data as certain information, such as aims, were not collected until recently. If an entry has been assigned an ID number (e.g. T1004), the full request has been submitted and is either approved, disapproved or in process. If an entry has no ID number, then it represents a submission that has not yet been reviewed. Search terms are applied across an entire requests application including variables not displayed below. A more specific, detailed search may yield better results depending upon your needs.


Search Terms:


Investigator: Oskar Hansson

Project Title: Improved precision of Alzheimer’s disease fluid biomarkers when using Amyloid-β40 or non-phosphorylated tau as a reference

Date: February 14, 2024

Request ID: D2404

Aim 1: Investigate if several already high performing CSF and plasma AD biomarkers can be improved by normalizing their concentrations to a reference protein (e.g., Aβ40 and non-phosphorylated mid-region tau [nP-tau]). For further details, see the file which was emailed to Marissa Streitz.

Aim 2:

Aim 3:

Aim 4:


Investigator: Iman Beheshti

Project Title: Association between inflammatory factors and accelerated brain aging in Alzheimer’s disease using OASIS3 data.

Date: February 5, 2024

Request ID:

Aim 1: To compute brain age estimation (as a new metric reflecting brain health) using advanced ML models and structural MRI data in the field of AD.

Aim 2: To uncover the impact of inflammatory factors on the increased development of AD and the rate of AD progression.

Aim 3: To understand the association between tau features on brain age estimation in diverse form of AD

Aim 4:


Investigator: Iman Beheshti

Project Title: Association between inflammatory factors and accelerated brain aging in Alzheimer’s disease.

Date: February 5, 2024

Request ID: D2403

Aim 1: To compute brain age estimation (as a new metric reflecting brain health) using advanced ML models and structural MRI data in the field of AD.

Aim 2: To uncover the impact of inflammatory factors on the increased development of AD and the rate of AD progression.

Aim 3: To understand the association between tau features on brain age estimation in diverse form of AD

Aim 4: To find the association between medications taken by patients with the risk of developing AD and AD progression using the brain age estimation model.


Investigator: Nelly Joseph-Mathurin

Project Title: Pathology correlates of biomarkers for neurovascular unit dysfunction in AD

Date: February 1, 2024

Request ID: D2402

Aim 1: Evaluate the relationship between CSF proteomics of NVU-related proteins against neuropathology at a global level

Aim 2: Evaluate the relationship between imaging biomarkers of vascular changes and neuropathology at global and regional levels

Aim 3:

Aim 4:


Investigator: Qian Liu

Project Title: Fusing Genomics and Neuroimaging: A Deep Learning Approach to diagnose Alzheimer’s Disease

Date: January 25, 2024

Request ID: D2401

Aim 1: Design and implement a deep learning model that effectively integrates genomics data with neuroimaging findings to identify biomarkers indicative of Alzheimer’s Disease.

Aim 2: Utilize the combined power of genomics and neuroimaging data to improve the accuracy and reliability of Alzheimer’s Disease diagnosis, surpassing the capabilities of models that rely on single-modality data.

Aim 3: Discover and analyze new correlations between genetic factors and brain imaging patterns in Alzheimer’s patients, contributing to a deeper understanding of the disease’s pathogenesis and aiding in the development of targeted treatments.

Aim 4:


Investigator: Qing Wang

Project Title: Association of CSF sTREM2 and plasma GFAP with an MRI measure of neuroinflammation

Date: December 18, 2023

Request ID: D2343

Aim 1: compare DBSI neuroinflammation index to in vivo CSF and plasma inflammation biomarkers (sTREM2 and GFAP) in the Knight ADRC cohorts

Aim 2:

Aim 3:

Aim 4:


Investigator: Shulan Hsieh

Project Title: Age prediction using resting state functional MRI

Date: December 15, 2023

Request ID: D2342

Aim 1: Compare model results by applying our developed model with the Data used in Millar et al. 2022 “Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer disease”

Aim 2:

Aim 3:

Aim 4:


Investigator: Marta Stojanovic

Project Title: Affective mechanisms of the decline in physical activity in preclinical AD

Date: December 13, 2023

Request ID: D2341

Aim 1: Examine whether AD pathology and mood contribute to physical activity.

Aim 2: Examine whether AD pathology and affective response to exercise contribute to physical activity.

Aim 3: Examine whether AD pathology and affective network connectivity contribute to physical activity.

Aim 4:


Investigator: Chihiro Sato

Project Title: Sex differences in Tau aggregation measured by Tau PET vs MTBR-tau

Date: December 8, 2023

Request ID: D2340

Aim 1: Determine sex-specific differences in Tau PET in AD vs age matched control

Aim 2: Determine sex-specific differences in CSF MTBR-tau243 in AD vs age matched control

Aim 3: Compare sex-specific differences measured by Tau PET vs CSF MTBR-tau243 in AD vs age matched control

Aim 4: Perform all analyses stratified by APOE genotype.


Investigator: Sarah Hartz

Project Title: Dementia screen in absence of collateral source

Date: November 16, 2023

Request ID: D2339

Aim 1: Use existing data to develop and evaluate a screening tool that can be administered without a collateral source

Aim 2:

Aim 3:

Aim 4: